Trump’s Tariffs Drive AstraZeneca’s $50 Billion US Investment—A Win for American Sovereignty

In a decisive move that underscores the power of an America First economic strategy, President Donald Trump announced on Tuesday that pharmaceutical giant AstraZeneca will invest a staggering $50 billion in the United States by 2030. This monumental commitment comes directly as a result of Trump’s hardline tariff threats aimed at reshaping global supply chains and protecting American industry. During a press briefing at the White House, President Trump connected this investment explicitly to his administration’s use of targeted tariffs, stating, "It’s an honor. It will be a very good investment, no doubt about it. So, thank you to AstraZeneca."...